A Study of Thienorphine Hydrochloride Tablets in Relapse Prevention Treatment of Opioid Dependence

Condition:   Opioid Dependence Interventions:   Drug: 0.2mg group;   Drug: 0.5mg group;   Drug: placebo control group Sponsors:   Wei Hao;   Beijing ziduhongye technology development co. LTD;   Institute of Pharmacology and Toxicology, Academy of Military Medical Science;   Shanghai Mental Health Center;   West China Hospital;   Wuhan Mental Health Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials